Billionaire hedge fund manager David Tepper is once again injecting himself into the affairs of Botox maker Allergan. The need for change is “readily apparent,” Tepper said in a letter to Allergan’s board, pointing to the company’s $4.3 billion loss last quarter, which sent the stock down 8.5 percent when the loss was announced last...
